IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-62386-6.html
   My bibliography  Save this article

A multimodal dataset for precision oncology in head and neck cancer

Author

Listed:
  • Marion Dörrich

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Matthias Balk

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Bavarian Cancer Research Center (BZKF))

  • Tatjana Heusinger

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Merciful Brothers Hospital St. Elisabeth)

  • Sandra Beyer

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Hamed Mirbagheri

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • David J. Fischer

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Hassan Kanso

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Bavarian Cancer Research Center (BZKF))

  • Christian Matek

    (Bavarian Cancer Research Center (BZKF)
    University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg)

  • Arndt Hartmann

    (Bavarian Cancer Research Center (BZKF)
    University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) and Comprehensive Cancer Center Alliance WERA (CCC WERA))

  • Heinrich Iro

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Bavarian Cancer Research Center (BZKF))

  • Markus Eckstein

    (Bavarian Cancer Research Center (BZKF)
    University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) and Comprehensive Cancer Center Alliance WERA (CCC WERA))

  • Antoniu-Oreste Gostian

    (University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
    Bavarian Cancer Research Center (BZKF)
    Merciful Brothers Hospital St. Elisabeth
    Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) and Comprehensive Cancer Center Alliance WERA (CCC WERA))

  • Andreas M. Kist

    (Friedrich-Alexander-Universität Erlangen-Nürnberg)

Abstract

Head and neck cancer is a common disease and is associated with a poor prognosis. A promising approach to improving patient outcomes is personalized treatment, which uses information from a variety of modalities. However, only little progress has been made due to the lack of large public datasets. We present a multimodal dataset, HANCOCK, that comprises monocentric, real-world data of 763 head and neck cancer patients. Our dataset contains demographical, pathological, and blood data as well as surgery reports and histologic images, that can be explored in a low-dimensional representation. We can show that combining these modalities using machine learning is superior to a single modality and the integration of imaging data using foundation models helps in endpoint prediction. We believe that HANCOCK will not only open new insights into head and neck cancer pathology but also serve as a major source for researching multimodal machine-learning methodologies in precision oncology.

Suggested Citation

  • Marion Dörrich & Matthias Balk & Tatjana Heusinger & Sandra Beyer & Hamed Mirbagheri & David J. Fischer & Hassan Kanso & Christian Matek & Arndt Hartmann & Heinrich Iro & Markus Eckstein & Antoniu-Ore, 2025. "A multimodal dataset for precision oncology in head and neck cancer," Nature Communications, Nature, vol. 16(1), pages 1-11, December.
  • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62386-6
    DOI: 10.1038/s41467-025-62386-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-62386-6
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-025-62386-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Paul C. Tumeh & Christina L. Harview & Jennifer H. Yearley & I. Peter Shintaku & Emma J. M. Taylor & Lidia Robert & Bartosz Chmielowski & Marko Spasic & Gina Henry & Voicu Ciobanu & Alisha N. West & M, 2014. "PD-1 blockade induces responses by inhibiting adaptive immune resistance," Nature, Nature, vol. 515(7528), pages 568-571, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Chunping Mao & Fuan Deng & Wanning Zhu & Leiming Xie & Yijun Wang & Guoyin Li & Xingke Huang & Jiahui Wang & Yue Song & Ping Zeng & Zhenpeng He & Jingnan Guo & Yao Suo & Yujing Liu & Zhuo Chen & Mingx, 2024. "In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Yu Feng & Wenjuan Ma & Yupeng Zang & Yanying Guo & Young Li & Yixuan Zhang & Xuan Dong & Yi Liu & Xiaojuan Zhan & Zhizhong Pan & Mei Luo & Miaoqing Wu & Ao Chen & Da Kang & Gong Chen & Longqi Liu & Ji, 2024. "Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    3. Jiekun Yang & Cassia Wang & Doris Fu & Li-Lun Ho & Kyriakitsa Galani & Lee Chen & Jose Gonzalez & Jolene Fu & Amy Y. Huang & Dennie T. Frederick & Liang He & Mukta Asnani & Rahul Tacke & Emily J. Robi, 2025. "Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma," Nature Communications, Nature, vol. 16(1), pages 1-19, December.
    4. Elaine Lai-Han Leung & Run-Ze Li & Xing-Xing Fan & Lily Yan Wang & Yan Wang & Zebo Jiang & Jumin Huang & Hu-Dan Pan & Yue Fan & Hongmei Xu & Feng Wang & Haopeng Rui & Piu Wong & Hermi Sumatoh & Michae, 2023. "Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    5. Rana Falahat & Anders Berglund & Patricio Perez-Villarroel & Ryan M. Putney & Imene Hamaidi & Sungjune Kim & Shari Pilon-Thomas & Glen N. Barber & James J. Mulé, 2023. "Epigenetic state determines the in vivo efficacy of STING agonist therapy," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    6. Tian-mei Zeng & Guang Yang & Cheng Lou & Wei Wei & Chen-jie Tao & Xi-yun Chen & Qin Han & Zhuo Cheng & Pei-pei Shang & Yu-long Dong & He-ming Xu & Lie-ping Guo & Dong-sheng Chen & Yun-jie Song & Chuan, 2023. "Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    7. Stefano Pierini & Rashid Gabbasov & Maria Cecilia Oliveira-Nunes & Rehman Qureshi & Alison Worth & Shuo Huang & Karan Nagar & Crystal Griffin & Lurong Lian & Yumi Yashiro-Ohtani & Kayleigh Ross & Chri, 2025. "Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    8. Markus Haake & Beatrice Haack & Tina Schäfer & Patrick N. Harter & Greta Mattavelli & Patrick Eiring & Neha Vashist & Florian Wedekink & Sabrina Genssler & Birgitt Fischer & Julia Dahlhoff & Fatemeh M, 2023. "Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    9. Kuang Du & Shiyou Wei & Zhi Wei & Dennie T. Frederick & Benchun Miao & Tabea Moll & Tian Tian & Eric Sugarman & Dmitry I. Gabrilovich & Ryan J. Sullivan & Lunxu Liu & Keith T. Flaherty & Genevieve M. , 2021. "Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    10. Darci Phillips & Magdalena Matusiak & Belén Rivero Gutierrez & Salil S. Bhate & Graham L. Barlow & Sizun Jiang & Janos Demeter & Kimberly S. Smythe & Robert H. Pierce & Steven P. Fling & Nirasha Ramch, 2021. "Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    11. Jeppe Sejerø Holm & Samuel A. Funt & Annie Borch & Kamilla Kjærgaard Munk & Anne-Mette Bjerregaard & James L. Reading & Colleen Maher & Ashley Regazzi & Phillip Wong & Hikmat Al-Ahmadie & Gopa Iyer & , 2022. "Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    12. Stacy K. Thomas & Max M. Wattenberg & Shaanti Choi-Bose & Mark Uhlik & Ben Harrison & Heather Coho & Christopher R. Cassella & Meredith L. Stone & Dhruv Patel & Kelly Markowitz & Devora Delman & Micha, 2023. "Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    13. Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    14. Lei Guan & Bin Wu & Ting Li & Lynn A. Beer & Gaurav Sharma & Mingyue Li & Chin Nien Lee & Shujing Liu & Changsong Yang & Lili Huang & Dennie T. Frederick & Genevieve M. Boland & Guangcan Shao & Tatyan, 2022. "HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    15. Mike B. Barnkob & Yale S. Michaels & Violaine André & Philip S. Macklin & Uzi Gileadi & Salvatore Valvo & Margarida Rei & Corinna Kulicke & Ji-Li Chen & Vitul Jain & Victoria K. Woodcock & Huw Colin-Y, 2024. "Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    16. Maria Pia Lenza & Leire Egia-Mendikute & Asier Antoñana-Vildosola & Cátia O. Soares & Helena Coelho & Francisco Corzana & Alexandre Bosch & Prodhi Manisha & Jon Imanol Quintana & Iker Oyenarte & Luca , 2023. "Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    17. Jia Wei & Xiaofeng Lu & Qin Liu & Yao Fu & Song Liu & Yang Zhao & Jiawei Zhou & Hui Chen & Meng Wang & Lin Li & Ju Yang & Fangcen Liu & Liming Zheng & Haitao Yin & Yang Yang & Chong Zhou & Ping Zeng &, 2023. "Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    18. Xiaofeng Liao & Wenxue Li & Hongyue Zhou & Barani Kumar Rajendran & Ao Li & Jingjing Ren & Yi Luan & David A. Calderwood & Benjamin Turk & Wenwen Tang & Yansheng Liu & Dianqing Wu, 2024. "The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    19. Ziyang Cao & Dongdong Li & Liang Zhao & Mengting Liu & Pengyue Ma & Yingli Luo & Xianzhu Yang, 2022. "Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    20. Thomas Thisted & F. Donelson Smith & Arnab Mukherjee & Yuliya Kleschenko & Feng Feng & Zhi-Gang Jiang & Timothy Eitas & Kanam Malhotra & Zuzana Biesova & Adejumoke Onumajuru & Faith Finley & Anokhi Ci, 2024. "VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62386-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.